Showing 1 - 1 results of 1 for search 'Hannah M Findlay', query time: 0.01s
Refine Results
-
1
CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression by Agapitos Patakas, Bochong Li, Naveen K Mehta, Kristan Meetze, Patrick A Baeuerle, Jennifer S Michaelson, Hannah M Findlay, Timothy B London
Published 2023-08-01
Article